Nanowire Field-Effect Transistor Biosensors

Nanowire field-effect transistor (FET) biosensors represent a convergence of nanoelectronics and molecular recognition, offering real-time, label-free detection of biomolecules through modulation of a conductive channel. Typically fabricated from semiconductor materials such as silicon, III–V compounds or carbon-based nanomaterials, nanowires provide a high surface-to-volume ratio that renders their electrical conductance exquisitely sensitive to local charge variations. Surface functionalisation with antibodies, aptamers or other recognition elements allows selective binding of targets ranging from nucleic acids and proteins to viral particles and small ions. The local electric field generated by target binding alters the carrier concentration in the nanowire, producing a measurable change in source–drain current. Key advantages include ultrahigh sensitivity—often reaching single-molecule resolution—rapid response times, low sample volumes, and compatibility with large-scale integration for multiplexed arrays. Challenges such as Debye screening in physiological buffers and device-to-device variability have driven innovations in channel geometry, surface chemistry and material strain engineering. Collectively, these developments promise transformative applications in point-of-care diagnostics, environmental monitoring and precision medicine.

Research from Nature Portfolio

Recent studies have demonstrated the power of two-dimensional materials integrated into FET architectures to advance biosensing performance. One approach employs patterned single-crystal graphene channels into multiple parallel segments to monitor DNA hybridisation kinetics and discriminate single-base mismatches quantitatively in real time. This multiplexed design achieves detection limits in the picomolar range and provides an analytical framework to estimate probe density and hybridisation efficiency, paving the way for high-throughput genetic screening. Another innovation leverages nanoscale deformation of monolayer graphene to create “electrical hot spots” that mitigate Debye screening effects. Such devices attain attomolar to zeptomolar sensitivity for nucleic acid detection in serum and buffer by exploiting concave regions that concentrate electric fields and open a band gap in the graphene channel for exponential current modulation. A complementary line of research utilises antibody- or aptamer-modified high electron mobility transistors (HEMTs) based on AlGaN/GaN heterostructures to detect proteins directly in undiluted physiological media. This design overcomes ionic strength limitations without sample pretreatment and delivers rapid, label-free quantification of biomarkers at clinically relevant levels.

Nanowire Field-Effect Transistor Biosensors publication trend

The graph below shows the total number of articles in nanowire field-effect transistor biosensors across all publications each year (not limited to Nature Index journals).

Technical terms

Field-effect transistor (FET) biosensor: A device in which a gate-modulated semiconductor channel forms the basis for label-free detection of analytes via changes in electrical current.

Nanowire: A quasi-one-dimensional structure with nanometre-scale diameter, offering high surface-to-volume ratio and sensitivity to surface charge perturbations.

Debye screening: The electrostatic shielding effect of ions in solution that limits the effective sensing range of charged biomolecules near the transistor surface.

Aptamer: A short, single-stranded nucleic acid sequence selected for high-affinity binding to a specific target molecule, used as a recognition element.

High electron mobility transistor (HEMT): A heterostructure FET exploiting two-dimensional electron gas at compound-semiconductor interfaces for sensitive, high-speed electrical responses.

References

1. Real-time reliable determination of binding kinetics of DNA hybridization using a multi-channel graphene biosensor. Nature Communications (2017).
2. Ultrasensitive detection of nucleic acids using deformed graphene channel field effect biosensors. Nature Communications (2020).
3. Beyond the Debye length in high ionic strength solution: direct protein detection with field-effect transistors (FETs) in human serum. Scientific Reports (2017).
4. Aptamer‐functionalized field‐effect transistor biosensors for disease diagnosis and environmental monitoring. Exploration (2023).
5. Field-Effect Transistor Biosensors for Biomedical Applications: Recent Advances and Future Prospects. Sensors (2019).